Evidence map›Paper›PMID 35936820›Full record

ReviewInternational journal of breast cancer2022

Breast Cancer in Adolescents and Young Adults Less Than 40 Years of Age in Nigeria: A Retrospective Analysis.

Atara Ntekim, Mojisola Oluwasanu, Oluwaponmile Odukoya

Open access · goldAbstract readReview
In one paragraph

Review in International journal of breast cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Atara NtekimDepartment of Radiation Oncology, College of Medicine, University of Ibadan, Nigeria.ORCID https://orcid.org/0000-0003-4830-8365
Mojisola OluwasanuDepartment of Health Promotion, College of Medicine, University of Ibadan, Nigeria.
Oluwaponmile OdukoyaDepartment of Radiation Oncology, College of Medicine, University of Ibadan, Nigeria.
University of Ibadan · NG

Funding

Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)K43TW010721 · FIC · COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN · PI NTEKIM, ATARA ISAIAH · 2018 to 2022
$409k
FIC NIH HHS K43 TW010721
6 · The paper itself

Abstract

Background: Breast cancer among adolescents and young adult (AYA) females aged 15-39 years is associated with different patterns of aggressiveness, as well as psychosocial and economic issues. At present, the burden of breast cancer among this age group is unknown in Nigeria. There is a need to determine the proportion of AYA with breast cancer in Nigeria. This will inform the development of breast cancer care programs appropriate for this age group. Objective: The objective of this study was to highlight the burden of breast cancer with an emphasis on AYAs in Nigeria and its implications. Methods: A retrospective review of data from cancer registries in Nigeria between 2009 and 2016 was carried out. Result: s. Among AYA females in Nigeria, breast cancer was by far the most common cancer, constituting 50% of all cancers and 51% (2798 of 5469) of all breast cancer cases. IA third (30.8%) of breast cancer cases in all centers studied were AYAs. Conclusion: The high proportion of AYA with breast cancer is an important feature suggesting that urgent actions are required to ensure early detection and improve breast cancer care among this age group.

Identifiers

PMID35936820
PMCPMC9355764
OpenAlexW4288696948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.